Small Cell Lung Cancer

Authors outlined advancements in chimeric antigen receptor-modified T (CAR-T) cell therapy for lung cancer, and accompanying challenges.

Findings of a meta-analysis suggest adding antiangiogenics to second-line treatment in non–small cell lung cancer (NSCLC) may improve survival outcomes, especially in younger patients.

Researchers used data to develop a nomogram that identified factors associated with worse prognoses in patients with non–small cell lung cancer (NSCLC) and liver metastases.

Writing in Journal of Internal Medicine, researchers examine potential barriers inhibiting uptake of low-dose CT lung cancer screening in Europe.

A recent study demonstrates certain driver mutations in patients with non–small cell lung cancer (NSCLC) may shorten disease-free survival after combination neoadjuvant immunotherapy and chemotherapy.

Integrating plasma next-generation sequencing (NGS) alongside tissue testing when determining lung cancer diagnosis may improve outcomes for patients.

Researchers analyzed declines in clinical trial enrollment and asked sites what mitigation strategies they employed to meet the reduction.

Researchers compared drug costs among hospitals, specialty pharmacies, and physician offices.

Patients who utilized a patient-reported outcome (PRO) symptom measurement tool reported superior postdischarge outcomes after lung cancer surgery compared with those who received usual care.

Patients with non–small cell lung cancer (NSCLC) reported superior mental health well-being during the COVID-19 pandemic compared with a control population that did not have cancer.

The national coverage determination will help detect early non-small cell lung cancer, CMS said.

Using data from a meta-analysis, researchers determined tumor-stroma ratio could serve as a survival predictor in non–small cell lung cancer (NSCLC).

The overdiagonsis identified in the current study also led to overtreatment in this population, authors found.

A meta-analysis on first-line treatment for non–small cell lung cancer (NSCLC) in clinical trials revealed that inclusion of dexamethasone along side chemotherapy and PD-L1 inhibitors yielded benefits in this patient population.

New research out today details the lack of price reductions seen among recently launched brand-name drugs for non–small cell lung cancer (NSCLC).

Researchers examined differences in lung cancer screening and follow-up rates among individuals residing in Hawaii.

A model developed by researchers in China could help identify patients with non–small cell lung cancer (NSCLC) most likely to benefit from anti– programmed death-ligand 1 (PD-L1) immunotherapy.

Investigators identified potential markers of chemotherapy efficacy in patients with non–small cell lung cancer.

A new analysis published in JAMA Oncology found the United States Preventive Services Task Force's (USPSTF) 2021 update to lung cancer screening recommendations helped close a racial disparity gap in screening rates.

A recent analysis provides updated data on non–small cell lung cancer in the United States.

An analysis concluded that cemiplimab may be more cost-effective than chemotherapy as first-line treatment for some US patients with non–small cell lung cancer (NSCLC).

Cullinan Oncology’s CLN-081 today received a Breakthrough Therapy Designation from the FDA for the treatment of locally advanced or metastatic non–small cell lung cancer (NSCLC).

This article presents a cost-effectiveness analysis of nivolumab vs docetaxel from the US payer perspective in non–small cell lung cancer (NSCLC) based on randomized phase 3 studies with a minimum 5 years of follow-up.

On World Lung Cancer Day, we explore current guidelines for lung cancer screening in the United States, implications of the COVID-19 pandemic, and disparities in mortality and access to care by race and socioeconomic status.

Kathryn Gold, MD, medical oncologist and associate professor of medicine at UC San Diego, who is a member of the NCCN guidelines panel for small-cell lung cancer, gives insight into the guidelines and the importance of frequent updates.